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Transgenic malaria parasites expressing fluorescent and bioluminescent proteins are
valuable tools to interrogate malaria-parasite biology and to evaluate drugs and vaccines.
Using CRISPR/Cas9 methodology a transgenic Plasmodium falciparum (Pf) NF54 line
was generated that expresses a fusion ofmCherry and luciferase genes under the control
of the Pf etramp10.3 gene promoter (line mCherry-luc@etramp10.3). Pf etramp10.3
is related to rodent Plasmodium uis4 and the uis4 promoter has been used to drive
high transgene expression in rodent parasite sporozoites and liver-stages. We examined
transgene expression throughout the complete life cycle and compared this expression
to transgenic lines expressing mCherry-luciferase and GFP-luciferase under control of
the constitutive gapdh and eef1a promoters. The mCherry-luc@etramp10.3 parasites
express mCherry in gametocytes, sporozoites, and liver-stages. While no mCherry signal
was detected in asexual blood-stage parasites above background levels, luciferase
expression was detected in asexual blood-stages, as well as in gametocytes, sporozoites
and liver-stages, with the highest levels of reporter expression detected in stage
III-V gametocytes and in sporozoites. The expression of mCherry and luciferase in
gametocytes and sporozoites makes this transgenic parasite line suitable to use in
in vitro assays that examine the effect of transmission blocking inhibitors and to analyse
gametocyte and sporozoite biology.
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INTRODUCTION
Transgenic rodent and human malaria parasites expressing
fluorescent and bioluminescent proteins are used extensively
to interrogate parasite biology and host-parasite interactions
associated with malaria pathology and as tools to evaluate
anti-parasite inhibitors and vaccines (Othman et al., 2017).
In comparison to transgenic rodent malaria parasites (RMP)
only a few Plasmodium falciparum (Pf ) transgenic parasites
expressing fluorescent or luminescent proteins are available.
Transgenic Pf parasites have been used to quantify effects
of inhibitors and antibodies either on blood-stage growth in
vitro using standard growth inhibition assays (Wilson et al.,
2010) or on transmission-blocking (TB) activity in the mosquito
in high-throughput screens using standard membrane feeding
assays (Vos et al., 2015; Lucantoni et al., 2016). For the TB
assays transgenic Pf (NF54 strain) parasite lines expressing
the GFP-luciferase fusion protein under control of either
the strong constitutive Pf hsp70 (Vos et al., 2015) or the
gametocyte-specific pfs16 promoters have been used (Lucantoni
et al., 2016). In addition, a transgenic Pf NF54 has been
described that expresses a GFP-luciferase fusion protein under
control of the constitutive Pf eef1a promoter (Vaughan et al.,
2012). This reporter line has been used to analyze liver
infection in immune-deficient humanized mice engrafted with
human liver tissue ((Sack et al., 2014; Flannery et al., 2018);
(Foquet et al., 2018)).
In multiple RMP transgenic lines the uis4 gene promoter
has been used to drive expression of different transgenes in
sporozoites and liver-stages, such as genes encoding mCherry,
ovalbumin or human Plasmodium proteins (Combe et al.,
2009; Panchal et al., 2012; Montagna et al., 2014; Hopp et al.,
2015; Longley et al., 2015, 2017; Singer et al., 2015) The
uis4 gene, a member of the small Plasmodium etramp gene
family, is highly transcribed in sporozoites and liver-stages and
encodes a parasitophorous vacuole membrane (PVM) protein
that surrounds the parasite in the infected hepatocyte. Although
uis4 transcripts are translationally repressed in sporozoites (Silvie
et al., 2014; Silva et al., 2016), transgenes expressed under
control of uis4 regulatory sequences are expressed as protein
in sporozoites since uis4 translational repression in sporozoites
is dependent on DNA sequences present within the uis4 open
reading frame (Silvie et al., 2014; Hopp et al., 2015). In this study,
we generated a transgenic Pf parasite, mCherry-luc@etramp10.3,
which encodes a fusion of the proteins mCherry and luciferase
(mCherry-Luc) expressed under the control of the promoter of
etramp10.3 (PF3D7_1016900). We selected this promoter since
etramp10.3 is related to uis4 and it also belongs to the etramp gene
family and both genes have the same syntenic genomic location.
It has been previously reported that etramp10.3 is expressed in Pf
sporozoites as well as in blood- and liver-stages, where the protein
is located at the PVM, similar to the location of UIS4 in liver-
stages of rodent malaria parasites (Mackellar et al., 2010). In this
study, as a blood-stage reporter control line, we also generated
a transgenic Pf parasite that expresses mCherry-Luc under the
control of the promoter of gapdh (PF3D7_1462800), mCherry-
luc@gapdh. The gapdh gene is constitutively expressed in blood-
stages (Aurrecoechea et al., 2009) and we recently showed that
the gapdh promoter drives high GFP expression in both asexual
blood-stages and in gametocytes (Mogollon et al., 2016).
We chose to generate mCherry-expressing Pf reporter lines as
such lines could be used to visualize interactions of Plasmodium
parasites with host-cells (e.g., cells of the immune system or
hepatocytes), which are often labeled with green fluorescent
proteins. Moreover, we fused the mCherry gene to firefly
luciferase, as luminescence can be used to quantify parasite
numbers (e.g., sporozoites and liver-stages) using standardized
and sensitive assays (Annoura et al., 2013; Le Bihan et al., 2016;
Swann et al., 2016). The mCherry-luciferase expression cassettes
were introduced using a CRISPR/Cas9 methodology into the
p47 gene locus, a non-essential locus that has been previously
used to introduce transgenes into the Pf genome (Talman et al.,
2010; Vaughan et al., 2012; Vos et al., 2015; Lucantoni et al.,
2016). Reporter gene expression of mCherry-luc@etramp10.3
line was analyzed throughout the complete parasite life cycle
and compared to transgenic lines expressing mCherry-luciferase
or GFP-luciferase under control of the constitutive gapdh
or eef1a promoters. We demonstrate mCherry and luciferase
expression inmCherry-luc@etramp10.3 gametocytes, sporozoites
and liver-stages.
MATERIALS AND METHODS
In vitro Cultivation of P. falciparum
Blood-Stages
P. falciparum (Pf ) parasites from the NF54 strain were used
(Mogollon et al., 2016). Parasites were cultured using standard
culture conditions in a semi-automated culture system as
described (Mogollon et al., 2016) Fresh human serum and human
red blood cells (RBC) were obtained from the Dutch National
Blood Bank (Sanquin Amsterdam, the Netherlands; permission
granted from donors for the use of blood products for malaria
research and microbiology tested for safety). RBC of different
donors were pooled every 2 weeks, washed twice in serum free
RPMI-1640 and suspended in complete culture medium to 50%
hematocrit. Human serum of different donors were pooled every
4–6 months and stored at −20◦C until required. Pf gametocytes
cultures were generated using standard culture conditions with
some modifications as described (Mogollon et al., 2016). Briefly,
parasites from asexual stage cultures were diluted to a final
parasitemia of 0.5% and cultures were followed during 14 days
without refreshing RBC. At day 14 the cultures were analyzed for
mature, stage V, gametocytes.
In addition, a transgenic P. falciparum (NF54) line (gfp-
luc@eef1a) was used that contains a reporter cassette with a fusion
gene of GFP and luciferase (GFP-Luc) under control of eukaryotic
elongation factor 1 alpha (eef1a) promoter (Vaughan et al., 2012).
Generation of the mcherry-luc@etramp10.3
and the mCherry-luc@gapdh Parasite
Lines
To create the mCherry-luc@etramp reporter line we used
a previously described Cas9 construct (pLf0019), containing
the Cas9 expression cassette with a blasticidin (BSD) drug-
selectable marker cassette (Mogollon et al., 2016) in combination
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with a sgRNA donor-DNA plasmid (pLf0049). The sgRNA-
donor DNA construct (pLf0049) contains a hdhfr-yfcu drug-
selectable marker (SM) cassette for selection with the drug
WR99210. To generate pLf0049, the intermediate plasmid
pLf0039 (Supplementary Figure 1) was modified by introducing
two homology regions targeting of p47 (PF3D7_1346800).
Homology region 1 (HR1) was amplified using primers P1/P2
and homology region 2 (HR2) with P3/P4 from Pf NF54
genomic DNA (see Supplementary Table 1 for primer details).
HR1 was cloned in pLf0039 using restriction sites StuII/SacII
and HR2 using ApaI/HindIII. Subsequently, a guide RNA
sgRNA targeting the p47 locus (gRNA019) was selected using
the Protospacer software (alphaversion; https://sourceforge.net/
projects/ protospacerwb/files/Release/), based on the best off
targets hits score throughout the genome given by Protospacer
and the total number of mismatches of the sgRNA with
respect to the PAM site. A 20 bp guide sgRNA sequence
(using the primers P5/P6), flanked on both sides by a 15
bp DNA sequence necessary for In Fusion cloning (HD
Cloning Kit; Clontech), was annealed and used to replace the
BtgZI adaptor in pLf0039 as previously described (Ghorbal
et al., 2014), resulting in pLf0047. The plasmid pLf0047 was
digested with BlnI and NruI to confirm successful cloning of
the sgRNA and the correct sequence of the sgRNA (using
primes P7/P8) confirmed by Sanger sequencing. An additional
intermediate plasmid, pLf0130 (Supplementary Figure 1) was
modified by replacing the existing promotor region of the gapdh
gene (PF3D7_1462800) by the promoter region of etramp10.3
promoter (PF3D7_1016900) of a reporter cassette containing
mCherry fused to luciferase with the 3’UTR region of histidine-
rich protein II (PF3D7_0831800; 626 bp obtained by digestion
of an intermediate plasmid pLf0053 Mogollon et al., 2016
with restriction sites ApaI/XbaI). The etramp10.3 promoter
region (1.7kb) was amplified from Pf NF54 genomic DNA
using the primers P9/P10 and cloned into pLf0130 using
restriction sites SacIII/XhoI or KpnI. Next, to obtain the
complete mcherry-luc@etramp10.3 expression cassette, pLf0130
was digested with ApaI/SacII and this cassette was cloned
in pLf0047 using the same enzymes, resulting in the final
construct pLf0049.
To create the mCherry-luc@gapdh reporter line we used
the Cas9 construct (pLf0019), described above, in combination
with a sgRNA donor-DNA plasmid (pLf0048). The sgRNA-
donor DNA construct (pLf0048) contains a hdhfr-yfcu drug-
selectable marker (SM) cassette for selection with the drug
WR99210. To generate pLf0048, an intermediate plasmid
CM269 (Supplementary Figure 1) was modified by inserting the
promoter region (1.6 kb) of the gapdh gene (PF3D7_1462800)
that was PCR-amplified from Pf NF54 genomic DNA using the
primers P11/P12 (Supplementary Table 1). CM269 was digested
with restriction enzymes NruI/XhoI and the gapdh promoter
was cloned into CM269 using the same enzymes, resulting in
construct pLf0130 (Supplementary Figure 1). Finally, to obtain
themcherry-luc@gapdh expression cassette pLf0130 was digested
with ApaI/SacII and this cassette was cloned in pLf0047 (see
above) using the same enzymes, resulting in the final construct
pLf0048 (Supplementary Figure 1).
Isolation of plasmids for transfection and transfection of
synchronized ring stage parasites was performed as described
(Mogollon et al., 2016) and parasites were transfected with
a mixture of ∼50 µg of each circular plasmid (Cas9 and
sgRNA/Donor DNA construct). After transfection, parasite
cultures were maintained under standard culture conditions
in the semi-automated culture system (see above). Selection
of transformed parasites was performed by applying “double”
positive selection 24 h after transfection using the drugs
WR99210 (2.6 nM) and BSD (5µg/ml) as described (Mogollon
et al., 2016). Drug pressure in the cultures was maintained
until thin blood-smears were parasite-positive (usually after
14 to 26 days). Positive selection will select for the parasites
that were transfected successfully with both plasmids (Cas9
and sgRNA/Donor constructs). Subsequently, both drugs were
removed from the cultures for 2–4 days, followed by applying
negative selection by addition of 5-Fluorocytosine as described
(Mogollon et al., 2016) in order to eliminate parasites that
retained the crRNA/Donor construct as episomal plasmid and
enriching for the transfected parasites containing the donor
DNA integrated into the genome. Negative drug pressure in the
cultures was maintained until thin blood-smears were parasite-
positive (usually after 7 days). After negative selection infected
RBC (iRBC) were harvested from cultures with a parasitemia of 4
to 10% for genotyping by diagnostic PCR and Southern analysis
(see next sections). Subsequently, selected parasites were cloned
by limiting dilution as has been described previously (Mogollon
et al., 2016). Cloned parasites were transferred in 10ml culture
flasks at 5% haematocrit and cultured under standard culture
conditions (see above) in the semi-automated culture system
for collection of parasites for further genotype and phenotype
analyses (see next section).
Genotyping of mcherry-luc@etramp 10.3
and mCherry-luc@gapdh Parasites
For genotyping diagnostic PCR and Southern analysis of digested
DNA were performed using DNA isolated from iRBC obtained
from 10ml cultures (parasitemia 3–10%). DNA was isolated
as described (Mogollon et al., 2016). Correct integration of
the donors constructs was analyzed by PCR amplification of
the mCherry-luciferase gene (primers P13/P14), the fragment
for 3’ integration (3’int; primers P15/P16) and the p47 gene
(ORF; primers P17/P18) (see Supplementary Table 1 for primer
sequences). The PCR fragments were amplified using Go-taq R©
DNA polymerase (Promega) following standard conditions with
an annealing temperature of 56◦C for 20 s and a elongation step
of 72◦C for 4min. All other PCR settings were according to
manufacturer’s instructions.
Southern blot analysis of digested DNA was performed with
HpaI digested genomic DNA (4 h at 37◦C). Digested DNA was
hybridized with probes targeting the p47 homology region 1
(HR1), amplified from Pf NF54 genomic DNA by PCR using the
primers P1/P2 and a second probe targeting ampicillin (Amp)
gene, obtained by digestion of the intermediate plasmid pLf0040
with AatII/PvuI (550bp).
Frontiers in Cellular and Infection Microbiology | www.frontiersin.org 3 April 2019 | Volume 9 | Article 96
Marin-Mogollon et al. P. falciparum Expressing mCherry-Luciferase
Phenotype Analysis of
mcherry-luc@etramp 10.3 and
mCherry-luc@gapdh Parasites
Asexual Blood-Stages
The growth rate of asexual blood-stages (parasitemia) was
monitored by determination of parasitemia in standard in vitro
cultures for a period of 4 days with a starting parasitemia between
0.1 and 0.5%. Parasitemia was determined either by FACS
analysis of iRBC or by counting parasitemia in Giemsa-stained
thin blood films. For FACS analysis iRBC were stained with the
DNA-specific dye Hoechst-33258 in 1ml of PBS by adding 4µl of
a 500µM stock-solution (final concentration 2µM), as has been
described previously (Mogollon et al., 2016). mCherry expression
of asexual blood-stages was analyzed by standard fluorescence
microscopy. In brief, 200 µl samples of iRBC were collected
from 10ml cultures with a parasitemia between 4 and 10% and
stained with the DNA-specific dye Hoechst-33342 by adding 4
µl of a 500µM stock-solution (final concentration 10µM) for
20min at 37◦C. Subsequently, 5 µl was placed on a microscopic
slide (mounted under a cover slip) and fluorescence of live
iRBC analyzed using a Leica fluorescence MDR microscope
(100x magnification). Pictures were recorded with a DC500
digital camera microscope using Leica LAS X software and with
the following exposure times: mCherry 0.6 s; Hoechst-33342
0.136 s; bright field 0.62 s (1x gain). Luciferase expression in
mCherry-luc@etramp asexual blood-stages was determined as
follows. A serial dilution of asexual blood-stages was prepared
from parasites samples that were collected (in triplicate) from
asexual blood-stage cultures with a final number of 5 × 106
parasites per sample. These were diluted with RPMI-1640 culture
medium containing uninfected RBC (5% haematocrit) to prepare
(triplicate) samples with 1 × 106, 1 × 105, 1 × 104, 1 ×
103, 1 × 102, 1 × 101 parasites, respectively. Samples of 40 µl
containing only uninfected RBC (5% haematocrit) were used as
controls. The cells were pelleted by centrifugation (800 g; 30 s)
and were lysed with 40 µl of cell culture Lysis 5X reagent from
Promega (1 in 5 dilution in miliQ water). The complete lysates
were collected in black 96-well plate (flat bottom) and luciferase
activity was measured after adding 50 µl of the Luciferase
substrate (Luciferase Assay System Promega). Luciferase activity
(in relative light units; RLU) was measured using the Glomax
multi detection system Luminometer (Promega) and the Instinct
software (Promega).
Gametocytes
Gametocyte production (stage V male/female gametocytes)
and exflagellation of male gametocytes were analyzed in
gametocyte cultures established as described previously (van
Dijk et al., 2010). For analysis of mCherry expression, stage
II -V gametocytes were collected at days 7, 9, 11, and 14.
Samples (200µl) were collected, pelleted by centrifugation (800 g;
30 s) and stained with Hoechst-33342 and mCherry expression
analysis using fluorescence microscopy as described for asexual
blood-stages. Luciferase expression was determined in mCherry-
luc@etramp gametocytes (stage III-IV) collected at day 11. A
similar serial dilution of gametocytes was prepared as described
for asexual blood-stages and luciferase activity in gametocytes
was determined as described for the asexual blood-stages.
Oocysts and Sporozoites
For analysis of mosquito stages (oocysts and sporozoites),
Anopheles stephensi mosquitoes were infected with day 14
gametocytes cultures using the standard membrane feeding assay
(SMFA) (Ponnudurai et al., 1987, 1989). Oocysts numbers and
mCherry expression in oocysts was determined at day 8 and 10
after infection. mCherry expression was analyzed using a Leica
fluorescence MDR microscope (100x magnification). Pictures
were recorded with a DC500 digital camera microscope using
Leica LAS X software and with the following exposure times:
mCherry 0.6 s; Hoechst-33342 0.136 s; bright field 0.62 s (1x
gain). Collection of salivary gland sporozoites for counting
numbers and expression of mCherry was performed at day
14 and 21 after feeding. For counting sporozoites, salivary
glands from 30 to 60 mosquitoes were dissected, collected
in 100 µl of RPMI-1640 pH 7.2 and homogenized using a
grinder. Sporozoites were counted using a Bürker cell counter
using phase-contrast microscopy. For mCherry expression, the
isolated sporozoite were pelleted by centrifugation (800 g; 5min).
The pellet was suspended in 40 µl 1X PBS and sporozoites
stained with Hoechst-33342 (10µM) for 30min at 37◦C. Of
this solution, 5 µl was placed on a microscopic slide (mounted
under a cover slip) and fluorescence of sporozoites in live was
analyzed using a Leica fluorescence MDR microscope (100x
magnification). Pictures were recorded with a DC500 digital
camera microscope using Leica LAS X software and with the
following exposure times: mCherry 0.6 s; Hoechst-33342 0.136 s;
bright field 0.62 s (1x gain).
Luciferase activity in mCherry-luc@etramp sporozoites was
determined in duplicate samples (total volume of 40 µl of RPMI)
of a serial dilution of 0.31 × 104-5.0 × 104 salivary glands
sporozoites. Fifty microliter of D-Luciferin (0.4 mg/ml; Perkin
Elmer Life Sciences, Waltham, USA) was added to the 40 µl of
diluted sporozoites in a black 96-well plate (flat bottom). The in
vivo imaging system Lumina (Caliper Life Sciences, USA) was
used to measure luciferase activity. Imaging data were analyzed
using the Living Image R© 4.5.5 software (Caliper Life Sciences,
USA). Bioluminescence images were acquired with a 12.5 cm field
of view (FOV), medium binning factor and an “auto-exposure”
time of maximum 2 min.
Liver-Stages
Liver-stages of mCherry-luc@etramp and gfp-luc@eef1a
were cultured in vitro using cryopreserved primary human
hepatocytes obtained from Tebu-bio (Tebu-bio.com–Life
science Research) and thawed according to the instructions of
Sekisui/Xenotech (Sekisui XenoTech, LLC; Kansas City). Cells
were cultured in Williams’s E culture medium supplemented
with 10% FCS, 1% penicillin-streptomycin, 1% fungizone, 0.1
IU/ml insulin and 70µM hydrocortisone 21-hemisuccinate
(Sigma). Hepatocytes were seeded in Greiner clear bottom white
96-well plates at a density of 5 × 104 cells per well, 2 days before
infection with sporozoites as described previously (Boes et al.,
2016). Sporozoites were collected from infected mosquitoes at
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day 21 after as described above and hepatocyte cultures (at 37◦C)
were infected with 5 × 104 sporozoites per well. Three hours
(h) after the addition of sporozoites, the cultures were washed
three times with 1X PBS to remove mosquito material as well as
sporozoites and complete Williams’s E medium was added and
cultures which were incubated overnight at 37◦C. The day after,
the culture medium was replaced and then was changed every
48 h until day 7.
Cultured cryopreserved primary human hepatocytes were
infected with 5 × 104 mCherry-luc@etramp10.3 and GFP-
luc@eef1α sporozoites per well of a 96-wells plate. Development
of liver-stages of these two transgenic lines at day 2, 4,
and 6 after infection was compared with WT liver-stages by
immunofluorescence using antibodies against the cytoplasmic
protein PfHSP70 (rabbit, anti-PfHSP70; 1:75 dilution of 1 mg/ml
stock solution StressMarqBiosciences) and secondary antibody
(goat anti-rabbit IgG AF594; 1:200 dilution of 4 mg/ml stock
solution Invitrogen). Hepatocyte and parasite nuclei were stained
with 300nMDAPI (InvitrogenD1306). Fluorescence signals were
visualized using a Cytation Imager (Biotek, Winooski, VT). The
percentage of infected hepatocytes, the size of the liver-stages and
the intensity of PfHSP70 staining were analyzed using the FIJI
image analysis software package (Schindelin et al., 2012).
For analysis of mCherry expression in liver-stages,
infected hepatocytes were fixed (at day 3, 4, and 5) with 4%
paraformaldehyde in 1X PBS during 1 h at room temperature.
After fixation the wells were washed three times with 1X PBS
and permeabilized with 20 µl of 0.5% triton in 1X PBS and
then blocked with 10% of FCS in 1X PBS for 1 h. Fixed cells
were washed with 1X PBS and incubated with monoclonal
antibodies against PfHSP70 (rabbit, anti-Pfhsp70; 1:200 dilution
of 100µg/ml stock solution StressMarqBiosciences) and
against mCherry (goat, anti-mCherry Mab Sicgen antibodies;
1:200 dilution of 3 mg/ml stock solution) for 1 h at room
temperature. Subsequently, cells were rinsed 3 times with
1X PBS and incubated with the secondary antibodies Alexa
Fluor R©488/594-conjugated chicken anti-rabbit and anti-goat
(Invitrogen Detection Technologies at 1:200). Finally, the cells
were washed again three times with 1X PBS and stained with
the DNA-specific dye Hoechst-33342 at a final concentration
of 10µM. Fixed cells were covered with 1-2 drops of an anti-
fading agent (Vectashield), and stained cells were analyzed
for fluorescence using a Leica fluorescence MDR microscope
(100x magnification). Pictures were recorded with a DC500
digital camera microscope using Leica LAS X software with
the following exposure times: Alexa 488: 0.7s; Alexa 594: 0.6s;
Hoechst 0.136s; bright field 0.62s (1x gain). Luciferase expression
in liver-stages was monitored daily by adding 150 µl of Bright-
Glo luciferase assay substrate (Promega, Madison, WI) to 150 µl
of culture medium to each well and luminescence was quantified
using a Synergy 2 multi-purpose plate reader (Biotek, Winooski,
VT). Background was determined by measuring wells with
uninfected hepatocytes.
The sensitivity of liver-stage development to atovaquone
determined bymeasurement of luminescence of infected primary
human hepatocytes maintained in 96-well plates and incubated
with a serial dilution of atovaquone. Atovaquone was serially
diluted in DMSO and then in Williams E culture medium to
reach a final DMSO concentration of 0.1%. Atovaquone was
added to the 96-well cultures 3hrs after adding 5x104 sporozoites
to cultures of primary human hepatocytes. Medium containing
drug was refreshed each day and the cultures were allowed to
proceed for 4 days after which luminescence was determined as
describe above.
Statistics
Data were analyzed using GraphPad Prism software package
5.04 (GraphPad Software, Inc). Significance difference analyses
betweenWT and the reporter linesmcherry-luc@etramp 10.3 and
gfp-luc@eef1a was performed using the unpaired Student’s t-test.
RESULTS AND DISCUSSION
In order to create a P. falciparum parasite that has high
reporter protein expression in sporozoites and/or liver-stages, we
selected the promoter of the etramp10.3 gene (PF3D7_1016900)
to drive gene expression. We selected the P. falciparum p47
gene (PF3D7_1346800) locus for introduction of the transgene
expression cassette into the genome as it has been shown
to be suitable for transgene expression without compromising
parasite development in blood- and liver-stages as well as
in A. stephensi mosquitoes (Talman et al., 2010; Vaughan
et al., 2012; Vos et al., 2015). We had previously generated
various transgenic reporter P. falciparum lines, where GFP-
expression cassettes were introduced into the p230p gene locus
(PF3D7_0208900), but disruption of this gene resulted in
parasites that could not complete mosquito stage development
(Marin-Mogollon et al., 2018). Using CRISPR/Cas9 methodology
a transgenic P. falciparum (Pf) parasite line was created that
encodes an mCherry-luciferase fusion gene under the control
of 1.7 kb of 5’ UTR of the etramp10.3 gene. This expression
cassette was introduced into the neutral p47 gene locus
(PF3D7_1346800) using a two plasmid CRISPR/Cas9 method;
a previously described Cas9 construct (pLf0019) was used that
contains the Cas9 expression cassette and a blasticidin (BSD)
drug-selectable marker cassette (Mogollon et al., 2016) and
a second plasmid (pLf0049) containing both the p47 sgRNA
and the donor DNA sequences (Supplementary Figure 1). The
pLf0049 plasmid contains the p47 targeting sequences, the
mCherry-luc@etramp10.3 expression cassette and a hdhfr-yfcu
drug-selectable marker cassette (see Figure 1A and Materials
and Methods section for details of the generation of the
constructs). This plasmid is designed to introduce the reporter
mCherry-luc@etramp10.3 cassette into the p47 gene locus by
double cross-over homologous recombination to repair the
double strand break (DSB) introduced into the p47 gene
locus (Figure 1A).
As a control line we created also a transgenic P. falciparum
(Pf) parasite line that contains an mCherry-luciferase fusion
gene under control of 1.6kb 5’UTR of the gene encoding the
glycolytic enzyme, gapdh (PF3D7_1462800). Recently we have
shown that this promoter drives high GFP expression in P.
falciparum blood-stages (Mogollon et al., 2016). The same Cas9
construct, pLf0019, was used in combination with a plasmid
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FIGURE 1 | Generation and characterization of a P. falciparum reporter line expressing mCherry-luciferase under control of the etramp10.3 promoter. (A) Schematic
representation of the Cas9 (pLf0019) and sgRNA/donor (pL0049) constructs used to introduce the mCherry-luciferase expression cassette into the P. falciparum p47
gene locus. The mCherry-luciferase fusion gene is under the control of the promoter of the etramp10.3 gene. The p47 homology regions (HR1, HR2) used to
introduce the donor DNA (i.e., the mCherry-luciferase expression cassette), location of primers (p), sizes of restriction fragments (H: HpaI; in red), and PCR amplicons
(in black) are indicated. Primer sequences (shown in black and bold) are shown in Supplementary Table 1. WT–wild type; bsd–blasticidin selectable marker (SM);
hdhfr::yfcu–SM in donor plasmid. mCh-luc@etramp–the final reporter line mCherry-luc@etramp10.3. (B) Southern analysis of HpaI restricted DNA (left panel) and
diagnostic PCR (right panel) to confirm correct integration of construct pLf0049 into the p47 locus [wild type (WT), transfected, uncloned (uncl) parasites, clones 3 and
4 of mCherry-luc@etramp parasites, and plasmid (PL)]. Digested DNA was hybridized with a probe targeting the homology region 1 of p47 [HR1; primers p3/p4; see
(A)], showing the expected different-sized DNA fragments [shown in red in (A)] in WT (8.2 kb) and mcherry-luc@etramp10.3 parasites (6.1 kb). The absence of
hybridization of digested DNA with a probe for ampicillin (amp) confirms the absence of donor-DNA plasmid and single cross-over event integration of construct
pLf0049 in clone 3. Diagnostic PCR of mCherry-luc@etramp clone 3 confirms the presence of the mCherry gene (lane 1; primers p13/p14; 716 bp), correct 3′
integration of the construct (lane 2; primers p15/p16; 2,188 bp) and absence of the p47 gene (lane 3; primers p17/p18; 216 bp). Primer locations and product sizes
are shown in (A) and primer sequences in Supplementary Table 1). Uncropped images of the PCR and Southern analyses are shown in
Supplementary Figures 5, 6.
(pLf0048) expressing the p47 sgRNA and p47 donor-DNA
sequences (Supplementary Figure 1). This plasmid is designed
to introduce the reporter mCherry-luc@gapdh and the hdhfr-
yfcu drug-selectable marker cassettes into the p47 gene locus
by double cross-over homologous recombination to repair
the double strand break (DSB) introduced into the p47 gene
locus (see Supplementary Figure 2A andMaterials andMethods
section for details of the generation of the pLf0048 construct).
Transfection of Pf wild type (WT) NF54 parasites was
performed using synchronized ring-stage parasites that were
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FIGURE 2 | Expression of mCherry and luciferase in asexual blood-stages and gametocytes of mcherry-luc@etramp10.3 and mcherry-luc@gapdh parasites.
(A) Fluorescence microscopy analysis of live mcherry-luc@etramp10.3 asexual blood-stages (@etramp). No mCherry fluorescence signal above background were
detected in the different stages. R, rings; T, trophozoites; ES, early schizonts; LS, late schizonts. Lower panel, an mCherry-positive schizont of the control line
mcherry-luc@gapdh (@gapdh). See Supplementary Figure 3A for other asexual stages of this control line. Nuclei were stained with Hoechst-33342. All pictures
were recorded with standardized exposure/gain times to visualize differences in fluorescence intensity [mCherry 0.7 s; Hoechst 0.136 s; bright field 0.62 s (1x gain)].
Bright field (BF), Hoechst (H), mCherry (mC), Merge (M). Scale bar, 4µm. (B) Fluorescence microscopy analysis of mCherry expression in live mcherry-luc@etramp10.3
gametocytes (@etramp). Gametocyte stage II, III, IV and V are shown. Lower panel, stage IV gametocyte of the control line mcherry-luc@gapdh (@gapdh). See
Supplementary Figure 3B for other gametocyte stages of this control line. Nuclei were stained with Hoechst-33342. All pictures were recorded with standardized
exposure/gain times to visualize differences in fluorescence intensity [mCherry 0.7 s; Hoechst 0.136 s; bright field 0.62 s (1x gain)]. Bright field (BF), Hoechst (H),
mCherry (mC), Merge (M). Scale bar, 7µm. (C) Correlation between luciferase expression (luminescence, RLU, photons/sec) and number of parasites in serial
dilutions series of asexual blood-stages (AS) and gametocytes stage III/IV (Gam) of the mcherry-luc@etramp10.3 line (3 independent experiments). Wild type Pf NF54
parasites (WT) were used as a control. Black dotted line: luminescence value of uninfected cells. The mean luminescence value of triplicate samples is shown; error
bars represent the standard deviation. Correlation coefficient r (two-tailed Spearman’s test: 103-107 parasites): 1.00; p = 0.016 for AS and 1.0; p = 0.016 for Gam.
transfected with ∼50 µg of each circular plasmid (Cas9 and
sgRNA/donor-DNA constructs; see Materials and Methods
section). Selection of transfected parasites containing both
plasmids was performed by applying “double” positive selection
with the drugs BSD andWR99210 until parasites were detectable
by thin blood-smear analysis (between day 14 to 26 post
transfection). Subsequently, parasites were cultured for 2–4
days without drugs, followed by the application of negative
(5-FC) selection to eliminate parasites that retain transfection
constructs (i.e., donor-DNA) as episomal plasmids and to enrich
for parasites in which the donor-DNA construct has integrated
into the parasite genome. Subsequently, drug-selected parasites
were cloned by limiting dilution. Genotyping of two clones of
the mCherry-luc@etramp10.3 line (exp.0064 cl3 and cl4) and
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four clones of the mCherry-luc@gapdh line (exp.0055cl2, 3, 4
and 6) by Southern analysis and PCR revealed integration of
the mCherry-luciferase cassettes into the p47 locus (Figure 1B;
Supplementary Figure 2B). Whereas, in all clones of mCherry-
luc@gapdh the donor DNA appears to be integrated by double
cross-over integration, plasmid DNA is present in clone 4
of mCherry-luc@etramp10.3 line (Figure 1B) indicating single
cross-over integration of pLf0049 in this clone. For further
phenotype characterization of the cloned transgenic lines
we selected mCherry-luc@etramp10.3 clone 3 and mCherry-
luc@gapdh clone 2. PCR analyses of these two clones confirmed
correct integration of the expression cassettes into the p47 gene
locus (Figure 1B; Supplementary Figure 2B). In vitro growth of
asexual blood-stages of clones of both lines was comparable to
the growth of asexual blood-stages of the parent wild type (WT)
NF54 strain (Supplementary Figure 2C) and the two clones of
both lines produced WT-comparable numbers of mature stage
V male and female gametocytes in standardized gametocyte
cultures (Supplementary Table 2).
Examination of mCherry and Luciferase
Expression of mCherry-luc@etramp10.3
and mCherry-luc@gapdh in Blood-Stages
We analyzed mCherry expression in the reporter parasites
by fluorescence-microscopy of cultured asexual blood-stages.
The mCherry-luc@etramp10.3 line did not exhibit clear
mCherry expression in asexual blood-stages (ring-forms,
trophozoites, and schizonts) and the fluorescent signals
were indistinguishable from background of uninfected red
blood cells (Figure 2A). In contrast, asexual blood-stages
of the control mCherry-luc@gapdh line showed mCherry
expression, in agreement with our previous analyses of
GFP expression in blood-stages of the GFP@gapdh line,
where the gene encoding GFP was under the control of
the gapdh promoter (Mogollon et al., 2016) (Figure 2A;
Supplementary Figure 3A).
Gametocytes of mCherry-luc@gapdh were mCherry positive,
again in agreement with our previous observations of the
GFP@gapdh parasites (Marin-Mogollon et al., 2018) (Figure 2B;
Supplementary Figure 3B). However, mCherry signals in
gametocytes were relatively weak in all stages during their
development (stage II-IV). The mCherry-luc@etramp10.3
parasites exhibit strong mCherry expression in stage III-
V gametocytes (Figure 2B), with weak mCherry signals
being detectable in at least 20% of stage II gametocytes,
increasing to more than 95% of stage III-V gametocytes
that were strongly mCherry positive. The high etramp10.3
promoter activity in gametocytes is in agreement with the
high levels of etramp10.3 transcripts and ETRAMP10.3
protein previously reported in gametocytes in genome-
wide transcriptomic and mass spectrometry analyses. Peak
etramp10.3 transcript abundance was observed in stage III
gametocytes (López-Barragán et al., 2011) and ETRAMP10.3
peptides were detected in proteomic analyses of mature male
and female gametocytes (Lasonder et al., 2016; Miao et al.,
2017), with higher protein expression in gametocytes than in
asexual blood-stages.
The absence of clear mCherry signals in mCherry-
luc@etramp10.3 asexual blood-stages was unexpected since
expression of ETRAMP10.3 in asexual blood-stages had been
detected by mass spectrometry-based proteomics (Florens
et al., 2002; Silvestrini et al., 2010) and also been confirmed
by immunofluorescence analysis using anti-ETRAMP10.3
antibodies (Mackellar et al., 2010). Moreover, unsuccessful
attempts to delete the P. falciparum etramp10.3 gene indicates
that it is essential during asexual blood-stage development
(Mackellar et al., 2010). It is possible that fluorescence
microscopy analysis is too insensitive to detect low level
mCherry expression from the mCherry-luciferase fusion
protein in asexual blood-stages. We therefore performed
luminescence assays to analyse luciferase expression inmCherry-
luc@etramp10.3 asexual blood-stages. Luminescence signals
in parasites obtained from pure asexual blood-stage cultures
were significantly higher than those of uninfected red blood
cells (p < 0.0005 in culture wells with more than 104 parasites;
Figure 2C), indicating that asexual blood-stages express the
mCherry-luciferase protein. Stage IV/V gametocytes obtained
from gametocyte cultures had on average 30-fold higher
luminescence values (3 exp.; range 15–60 fold) compared to
asexual blood-stages. The luminescence values obtained from
mCherry-luc@etramp10.3 gametocyte (IV/V) or mixed asexual
stage dilution series demonstrate a linear relationship between
the number of parasites and signal intensity in the range of 1
× 103 to 1 × 107 parasites for gametocytes and 1 × 104 to 1 ×
107 for asexual blood-stage parasites (Figure 2C). Combined
our observations show that mCherry-luc@etramp10.3 parasites
have high level expression of mCherry and luciferase in stage
III-V gametocytes and low-level expression of luciferase in
asexual blood-stages.
The essential role of ETRAMP10.3 during asexual blood-
stage development and its expression in asexual blood-stages
and gametocytes is in contrast to expression of the UIS4
protein of the rodent parasites, P. berghei and P. yoelii. The
P. berghei and P. yoelii uis4 gene is dispensable for blood-
stage development s (Kaiser et al., 2004; Mueller et al.,
2005) and there is no evidence that uis4 is expressed in
blood-stages either from proteomic or transcriptomic analyses
[www.PlasmoDB.org; (Otto et al., 2014)]. In studies using
transgenic parasites expressing fluorescent and/or luminescent
proteins either under control of the uis4 promoter or fused to
UIS4 we are unable able to detect these reporters in blood-
stage parasites (Grützke et al., 2014; Hopp et al., 2015). In
contrast UIS4 has been show to play a vital role during
liver-stage development in both P. berghei and P. yoelii
(Kaiser et al., 2004; Mueller et al., 2005). In a previous
study, where the P. yoelii uii4 gene was replaced with the
etramp10.3 gene, it was demonstrated that ETRAMP10.3 is
unable to complement the function of UIS4 in P. yoelii liver-
stages (Mackellar et al., 2010). Combined, these observations
indicate that UIS4 and ETRAMP10.4 may have different,
or only partially overlapping, roles in rodent and human
malaria parasites.
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FIGURE 3 | Expression of mCherry and luciferase in oocyst and sporozoites of mcherry-luc@etramp10.3 and mcherry-luc@gapdh parasites. (A) Upper panel:
Representative mCherry-fluorescence microscopy image of a live mcherry-luc@etramp10.3 oocyst in A. stephensi mosquitoes at day 10 after infection (@etramp). No
mCherry fluorescence signal above background was detected in oocysts. Lower panel: Representative mCherry-fluorescence microscopy image of a live oocysts of
the control line mcherry-luc@gapdh (@gapdh). Bright field (BF), mCherry (mC). Scale bar, 20µm. (B) Representative mCherry-fluorescence microscopy images of live
salivary glands sporozoites collected at day 21 after infection of mosquitoes. Left panel: mcherry-luc@etramp10.3 (@etramp) sporozoites. Middle panel: sporozoites of
the control line mcherry-luc@gapdh (@gapdh). Right panel: wild type (WT) Pf NF54 sporozoites. Nuclei were stained with Hoechst33342. Bright field (BF), Hoechst
(H), mCherry (mC), Merge (M). Scale bar, 7µm. (C) Correlation between luciferase expression (luminescence, RLU) and number of sporozoites in serial dilutions series
(in duplicate) of live mCherry@etramp10.3 salivary gland sporozoites. Upper panel: Representative luminescence measurements of live sporozoites determined in
96-well plates. From left to right, rainbow images of a serial dilution of sporozoites (from 0, 0.3, 0.6, 1.2, 2.5, and 5.0 × 104 sporozoites). Relative levels of
luminescence range from low (blue), to medium (green), to high (yellow/red). Lower panel: Correlation between luciferase expression (luminescence, RLU,
photons/sec) and number of sporozoites. Black dotted line: luminescence values of wells without sporozoites. The mean luminescence values of duplicate samples is
shown; error bars represent the standard deviation. Correlation coefficient r (two-tailed Spearman’s test): 0.99; p = 0.016.
Examination of mCherry and Luciferase
Expression of mCherry-luc@etramp10.3,
mCherry-luc@gapdh, and GFP-luc@eef1α
in Oocysts and Sporozoites
We examined mCherry expression in oocysts and sporozoites,
collected from Anopheles stephensi mosquitoes, which were fed
with mCherry-luc@etramp10.3 gametocytes using the standard
membrane feeding assay. This line produced oocysts and
sporozoites in the same range as wild type (WT) NF54
parasites (Supplementary Table 2). Weak mCherry signals
were detected in maturing mCherry-luc@etramp10.3 oocysts
containing sporozoites (at day 8 and 11 after feeding; Figure 3A),
but mCherry signals were not above the background mCherry
signals observed with WT oocysts. In contrast, the oocysts (day
8) of the control line mCherry-luc@gapdh were clearly mCherry-
positive (Figure 3A).
In contrast to the mCherry negativemCherry-luc@etramp10.3
oocysts, mCherry-luc@etramp10.3 sporozoites collected from
salivary glands exhibited strong mCherry expression, whereas
lower mCherry signals were detected in mCherry-luc@gapdh
sporozoites (Figure 3B; Supplementary Figure 4). The activity
of the etramp10.3 promoter in salivary gland sporozoites
is in agreement with detection of multiple ETRAMP10.3
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FIGURE 4 | Liver stage development of mcherry-luc@etramp10.3 parasites and expression of mCherry and luciferase. (A) Development of liver-stages of
mCherry-luc@etramp10.3 in cultured cryopreserved primary human hepatocytes and comparison with wild type (WT) and GFP-luc@eef1α. Shown are the percentage
of infected hepatocytes (left graph), the size of liver-stages (middle graph; mean surface area; arbitrary units - a.u.) and the fluorescence intensity of PfHSP70 staining
(right graph; arbitrary units a.u. ×106). Hepatocytes were infected with 5 × 104 sporozoites and liver-stage development was analyzed at day 2, 4, and 6 after
infection. At least 20 parasites were assessed at each time point. nd: not determined. Significance values (unpaired two-tailed t-test): n.s.–not significant.
(B) Representative mCherry-fluorescence microscopy images of a fixed mcherry-luc@etramp10.3 liver stages at day 3, 4, and 5 after infecting cryopreserved primary
human hepatocytes with sporozoites. Fixed hepatocytes were stained with rabbit anti-PfHSP70 and goat anti-mCherry antibodies. Secondary conjugated antibodies
used: anti-IgG from rabbit Alexa Fluor® 488 (green) or anti-IgG from goat Alexa Fluor® 594 (red). Nuclei stained with Hoechst-33342. All pictures were recorded with
standardized exposure/gain times; Alexa Fluor® 488 (green) 0.7 s; anti-IgG Alexa Fluor® 594 (red) 0.6 s; Hoechst (blue) 0.136 s; bright field 0.62 s (1x gain). Bright field
(BF), Hoechst (H), anti-PfHSP70 (αh), mCherry (mC), Merge (M). Scale bar, 10µm. mCherry fluorescence was analyzed using mcherry-luc@etramp10.3 cl3 in two
independent experiments. (C) luciferase expression (luminescence, RLU, photons/sec) in sporozoites (spz) and in liver-stages from mCherry-luc@etramp10.3 cl3 and
the control line gfp-luc@eef1a. Cultured cryopreserved primary human hepatocytes were infected with 5 × 104 sporozoites and luminescence was measured during a
7 days period. Uninfected hepatocytes were used as a control (Black circle). The mean luminescence value of duplicate samples is shown; error bars represent the
standard deviation. (D) Sensitivity of mCherry-luc@etramp10.3 liver-stages to atovaquone ([ATQµM], concentration in micromolar). Inhibition of liver-stage
development was determined in a single experiment by measurement of luminescence at day 4 after infection of cultured cryopreserved primary human hepatocytes
with 5 × 104 sporozoites. The IC50 value (7.9 nM) was calculated by non-linear regression using GraphPad Prism software package 5.04.
Frontiers in Cellular and Infection Microbiology | www.frontiersin.org 10 April 2019 | Volume 9 | Article 96
Marin-Mogollon et al. P. falciparum Expressing mCherry-Luciferase
peptides in P. falciparum sporozoite proteomes (Lindner
et al., 2013; Swearingen et al., 2016). Expression of luciferase
in mCherry-luc@etramp10.3 sporozoites was examined and
luminescence signals from a dilution series of purified
sporozoites exhibit a linear relationship between sporozoite
number and luminescence intensity in the range of 1.25× 104 to
5× 104 sporozoites (Figure 3C).We compared the luminescence
signals of mCherry-luc@etramp10.3 sporozoites (5 × 104) with
that those of a previously described transgenic sporozoite line
that expresses GFP-luciferase fusion protein under control
of the eef1α promoter (GFP-luc@eef1α) (Vaughan et al.,
2012). The luminescence signal of mCherry-luc@etramp10.3
sporozoites was 14-fold higher than the luminescence
signal obtained from the same number of GFP-luc@eef1α
sporozoites (Figure 4).
Examination of mCherry and Luciferase
Expression of mCherry-luc@etramp10.3
and GFP-luc@eef1α in Liver-Stages
We next analyzed reporter expression in liver-stages; however,
since mCherry-luc@gapdh sporozoites showed low mCherry
expression, we compared mCherry-luc@etramp10.3 liver-stages
directly with GFP-luc@eef1α parasites as it has been reported
that sporozoites and liver-stages of this line expresses both GFP
and luciferase and this line has been used to analyse Pf liver
stage development (Vaughan et al., 2012; Sack et al., 2014;
Flannery et al., 2018; Foquet et al., 2018). Cultured cryopreserved
primary human hepatocytes were infected with 5x104 mCherry-
luc@etramp10.3 or GFP-luc@eef1α sporozoites per well of a
96-wells plate. Development of liver-stages at day 2, 4, and 6
after infection of the two transgenic lines and WT liver-stages
was examined by immunofluorescence using a rabbit polyclonal
antibody against the cytoplasmic P. falciparum protein PfHSP70.
The percentage of infected hepatocytes, the size of the liver-stages
and the intensity of HSP70 staining were comparable between
the transgenic and WT parasites at day 4 after infection and
liver-stages of both transgenic lines were comparable at day 6
(Figure 4A).
Expression of mCherry in mCherry-luc@etramp10.3 liver-
stages was analyzed at day 3, 4, and 5 after hepatocyte infection
by immunofluorescence assay using anti-mCherry antibodies;
mCherry signals were detectable in every Hsp70 positive-liver
stage parasite on all days (Figure 4B). Expression of luciferase
in liver-stages was also examined by luminescence assays
(Figure 4C; in duplicate) and we compared the luminescence
signals of mCherry-luc@etramp10.3 with GFP-luc@eef1α at the
same point of development. The luminesce signals of mCherry-
luc@etramp10.3 liver-stages, while significantly higher than
background levels with a peak of expression at day 5 (unpaired
T-test:∗∗∗p ≤ 0.0001), were between 2.2 to 7.6 fold lower than
GFP-luc@eef1α from day 3 to 7 (Figure 4C).
To determine if mCherry-luc@etramp10.3 parasites could be
used in a plate-based assay to test drug sensitivity of liver-stage
parasites we performed a drug assay using atovaquone, which
has potent activity against intra-hepatic parasites (Baragaña
et al., 2015). The in vitro inhibition of P. falciparum liver-stage
development was determined by measuring luminescence signals
of mCherry-luc@etramp10.3-infected hepatocytes maintained in
96-well plates and incubated with different concentrations of
atovaquone (0.001–100 nM). Atovaquone was added to the 96-
well cultures of primary human hepatocytes 3 h after the addition
of 5 × 104 sporozoites and the cultures were allowed to proceed
for 4 days, after which luminescence was determined. In this
assay we determined an IC50 value of atovaquone of 7.9 nM
(Figure 4D), which is comparable to the previously established
IC50 value of atovaquone against liver-stages (Delves et al., 2012).
Combined, our observation show high mCherry and
luciferase expression in gametocytes and sporozoites of the
mCherry-luc@etramp10.3 line. Although both mCherry and
luciferase expression is detected in liver stages, luciferase
expression driven by the etramp10.3 promoter is lower than
luciferase expression under the eef1α promoter.
In summary: As with rodent malaria parasites the
development and expansion of reporter lines in P. falciparum
would increase the range of analyses that can more easily
be performed, both to interrogate P. falciparum gene
function at different points of development and to permit
the miniaturization and rapid screening of compounds or
immune sera that target the parasite at different points
of development. Specifically, the expression of mCherry
(red) instead of GFP (green) can be an critical advantage,
especially when transgenic parasites/sporozoites will be used in
assays using GFP-expressing host cells. In addition, parasites
expressing mCherry in gametocytes will be valuable tools
in cross-fertilization assays between GFP-expressing and
mCherry expressing parasites (Ukegbu et al., 2015, 2017) for
gaining a better understanding of parasite fertilization and
mosquito-stage development.
The knowledge of expression of reporters under different
promoters, such as the etramp10.3, can be useful for generation
of additional (gene knock-out/mutated) mutants that require
the expression of transgenes in specific life cycle stages. In
contrast to the high expression in gametocytes and sporozoites
our studies indicate that the etramp10.3 promoter is less suitable
for high reporter expression in liver stages, which is unexpected
based on the use of the uis4 promoter of rodent parasites. We
demonstrate that the reporter expression in sporozoites under
control of the etramp10.3 promoter is much higher than under
control of the eef1a promoter and therefore this line can be
a valuable tool for studies on the biology of P. falciparum
sporozoites, for example to visualize sporozoite migration studies
in human skin explants (performed in our laboratory) or to
visualize and quantify P. falciparum sporozoite invasion of
human hepatocytes.
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